Pregnancy Outcomes After Semaglutide Exposure.
作者信息
Kolding Line, Henriksen Jakob Nørgaard, Sædder Eva Aggerholm, Ovesen Per Glud, Pedersen Lars Henning
机构信息
Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
出版信息
Basic Clin Pharmacol Toxicol. 2025 Apr;136(4):e70021. doi: 10.1111/bcpt.70021.
Abstract
摘要
相似文献
1
Pregnancy Outcomes After Semaglutide Exposure.司美格鲁肽暴露后的妊娠结局。
Basic Clin Pharmacol Toxicol. 2025 Apr;136(4):e70021. doi: 10.1111/bcpt.70021.
2
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).在 2 型糖尿病患者中比较每周一次胰高血糖素样肽-1 受体激动剂（OW GLP-1RAs）与二肽基肽酶-4 抑制剂（DPP-4is）的降糖和减重效果的真实世界疗效（RELATE）。
Clin Drug Investig. 2024 Apr;44(4):271-284. doi: 10.1007/s40261-024-01354-2. Epub 2024 Mar 20.
3
Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach.从其他 GLP-1 受体激动剂转换为司美格鲁肽对 HbA1c 和体重的影响：基于模型的方法。
Diabetes Obes Metab. 2019 Jan;21(1):43-51. doi: 10.1111/dom.13479. Epub 2018 Aug 23.
4
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.一项系统文献综述和网状荟萃分析：比较在既往接受1-2种口服抗糖尿病药物治疗的2型糖尿病患者中，每周一次的司美格鲁肽与其他胰高血糖素样肽-1（GLP-1）受体激动剂的疗效。
Diabetes Ther. 2018 Jun;9(3):1149-1167. doi: 10.1007/s13300-018-0424-2. Epub 2018 Apr 19.
5
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.一项系统文献综述和网状荟萃分析：比较既往接受基础胰岛素治疗的2型糖尿病患者中，每周一次司美格鲁肽与其他胰高血糖素样肽-1（GLP-1）受体激动剂的疗效
Diabetes Ther. 2018 Jun;9(3):1233-1251. doi: 10.1007/s13300-018-0428-y. Epub 2018 Apr 30.
6
The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy.司美格鲁肽和胰高血糖素样肽-1受体激动剂对非动脉性前部缺血性视神经病变风险的影响。
Am J Ophthalmol. 2025 Jun;274:24-31. doi: 10.1016/j.ajo.2025.02.025. Epub 2025 Feb 25.
7
A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes.一项在日本2型糖尿病患者中比较司美格鲁肽每周一次与其他GLP-1受体激动剂的网状Meta分析。
Diabetes Ther. 2018 Jun;9(3):973-986. doi: 10.1007/s13300-018-0397-1. Epub 2018 Mar 24.
8
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®).胰高血糖素样肽-1 受体激动剂（GLP-1 RAs）与自杀：一项使用向世界卫生组织药物警戒数据库（VigiBase®）报告进行的复制研究。
J Affect Disord. 2025 Jan 15;369:922-927. doi: 10.1016/j.jad.2024.10.062. Epub 2024 Oct 19.
9
Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity.司美格鲁肽与度拉鲁肽对2型糖尿病合并肥胖症患者心外膜脂肪厚度的影响。
J Endocr Soc. 2020 Mar 13;4(4):bvz042. doi: 10.1210/jendso/bvz042. eCollection 2020 Apr 1.
10
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.司美格鲁肽与非动脉炎性前部缺血性视神经病变
JAMA Ophthalmol. 2025 Apr 1;143(4):304-314. doi: 10.1001/jamaophthalmol.2024.6555.
本文引用的文献
1
Glucagon-like peptide-1 receptor agonist use in pregnancy: a review.胰高血糖素样肽-1受体激动剂在妊娠中的应用：综述
Am J Obstet Gynecol. 2025 Jan;232(1):17-25. doi: 10.1016/j.ajog.2024.08.024. Epub 2024 Aug 23.
2
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy.胰高血糖素样肽-1受体激动剂及其他二线抗糖尿病药物在孕早期的安全性
JAMA Intern Med. 2024 Feb 1;184(2):144-152. doi: 10.1001/jamainternmed.2023.6663.
3
Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence.GLP-1 激动剂和 SGLT2 抑制剂在妊娠和哺乳期对后代结局的影响：证据的系统评价。
Front Endocrinol (Lausanne). 2023 Oct 10;14:1215356. doi: 10.3389/fendo.2023.1215356. eCollection 2023.
4
BCPT 2023 policy for experimental and clinical studies.BCPT 2023年实验与临床研究政策。
Basic Clin Pharmacol Toxicol. 2023 Oct;133(4):391-396. doi: 10.1111/bcpt.13944. Epub 2023 Sep 27.
5
Pharmacologic Treatment of Obesity in Reproductive Aged Women.育龄女性肥胖的药物治疗
Curr Obstet Gynecol Rep. 2023 Jun;12(2):138-146. doi: 10.1007/s13669-023-00350-1. Epub 2023 Feb 27.
6
Maternal antipsychotic use during pregnancy and congenital malformations.孕妇使用抗精神病药物与先天性畸形。
Am J Obstet Gynecol MFM. 2023 Jun;5(6):100950. doi: 10.1016/j.ajogmf.2023.100950. Epub 2023 Apr 2.
7
Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations.临床洞察：司美格鲁肽用于成人慢性体重管理：患者选择和特殊考虑。
Drug Des Devel Ther. 2022 Dec 29;16:4449-4461. doi: 10.2147/DDDT.S365416. eCollection 2022.
Zotero 插件